Calendar

Financial Releases

Date Title  
Toggle Summary AbbVie Announces $5 Billion Increase to Stock Repurchase Program
NORTH CHICAGO, Ill. , Dec. 13, 2018 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) has authorized a $5 billion increase to AbbVie's existing stock repurchase program. Purchases may be made from time to time at management's discretion.
Toggle Summary AbbVie to Present at the Evercore ISI Conference
NORTH CHICAGO, Ill. , Nov. 13, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Evercore ISI HealthConX Conference on Tuesday, November 27, 2018. Bill Chase , executive vice president, finance and administration, will present at 8
Toggle Summary AbbVie Reports Third-Quarter 2018 Financial Results
- Reports Third-Quarter Diluted EPS of $1.81 on a GAAP Basis; Adjusted Diluted EPS of $2.14 Reflects Growth of 51.8 Percent - Delivers Third-Quarter Net Revenues of $8.236 Billion on a GAAP Basis; Adjusted Net Revenues of $8.236 Billion Increased 18.5 Percent on an Operational Basis - Third-Quarter
Toggle Summary AbbVie to Host Third-Quarter 2018 Earnings Conference Call
NORTH CHICAGO, Ill. , Sept. 17, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will announce its third-quarter 2018 financial results on Friday, November 2 2018 , before the market opens. AbbVie will host a live webcast of the earnings conference call
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , Sept. 7, 2018 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.96 per share. The cash dividend is payable Nov. 15, 2018 to stockholders of record at the close of business on Oct. 15, 2018 .
Toggle Summary AbbVie to Present at the Morgan Stanley 16th Annual Global Healthcare Conference
NORTH CHICAGO, Ill. , Aug. 28, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Morgan Stanley 16 th  Annual Global Healthcare Conference on Wednesday, September 12, 2018. Bill Chase , executive vice president and chief financial
Toggle Summary AbbVie Reports Second-Quarter 2018 Financial Results
- Reports Second-Quarter Diluted EPS of $1.26 on a GAAP Basis; Adjusted Diluted EPS of $2.00 Reflects Growth of 40.8 Percent - Delivers Second-Quarter Net Revenues of $8.278 Billion on a GAAP Basis; Adjusted Net Revenues of $8.258 Billion Increased 17.1 Percent on an Operational Basis -
Toggle Summary AbbVie to Host Second-Quarter 2018 Earnings Conference Call
NORTH CHICAGO, Ill. , July 10, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will announce its second-quarter 2018 financial results on Friday, July 27, 2018 , before the market opens. AbbVie will host a live webcast of the earnings conference call at
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , June 14, 2018 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.96 per share.  The cash dividend is payable Aug. 15, 2018 to stockholders of record at the close of business on July 13, 2018 .
Toggle Summary AbbVie Announces Final Results of Tender Offer
NORTH CHICAGO, Ill. , June 4, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV) today announced the final results of its modified Dutch auction tender offer, which expired at 12:00 midnight, New York City time, at the end of May 29, 2018 . AbbVie has accepted for purchase 72,815,534 shares of its common